Search

Displaying results 6351 - 6360 of 10000 in total
  1. Drug

    RESP301

    go.drugbank.com/drugs/DB16497
    Investigational

    RESP301 was also studied in a terminated trial (NCT05101915) for patients with mycobacterium abscesses and cystic fibrosis and in a completed trial with results (NCT04460183) for efficacy and safety in … Additionally, RESP301 was investigated in a withdrawn trial (NCT04842331) for preventing viral exposure and transmission of COVID-19 and in a not yet recruiting trial (NCT04386070) for preventing pulmonary

  2. Drug

    Ultevursen

    go.drugbank.com/drugs/DB17835
    Investigational

    It was developed by ProQR Therapeutics and is being investigated for the treatment of retinitis pigmentosa.

  3. Drug

    BACTEK-R

    go.drugbank.com/drugs/DB16526
    Investigational

    MV130 contains different components of whole heat-inactivated gram-positive and -negative bacteria that are involved in upper and lower respiratory infections. … These include streptococcus pneumoniae and staphylococcus aureus.

  4. Drug

    Tanespimycin

    go.drugbank.com/drugs/DB05134
    Investigational

    Tanespimycin, manufactured by Conforma Therapeutics is under development as a small molecule inhibitor of heat shock protein 90 (HSP90).

  5. Indication

    Ankylosing Spondyloarthritis

    go.drugbank.com/conditions/DBCOND0057824
    Drugs: Aceclofenac · Acetaminophen · Adalimumab · Betamethasone · Bupivacaine · Celecoxib +29 more
    Synonyms: Ank spond
  6. Drug

    CMLVAX100

    go.drugbank.com/drugs/DB05164
    Experimental

    It is developed by Breakthrough Therapeutics and has completed phase I of its clinical trial.

  7. Drug

    rhIGFBP-3

    go.drugbank.com/drugs/DB05897
    Investigational

    It is developed by Insmed and is currently under phase I of the clinical trial.

  8. Drug

    OPC-28326

    go.drugbank.com/drugs/DB05461
    Experimental

    , carotid, vertebral, renal, and mesenteric blood flows. … It is currently being investigated in the treatment of peripheral vascular diseases and Raynaud's syndrome.

  9. Drug

    Tiropramide

    go.drugbank.com/drugs/DB13091
    Investigational

    Tiropramide is under investigation in clinical trial NCT01629212 (Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome).

    Categories: Alimentary Tract and Metabolism, Amino Acids, Peptides, and Proteins
  10. Drug

    Itolizumab

    go.drugbank.com/drugs/DB16207
    Investigational

    Itolizumab is under investigation in clinical trial NCT04605926 (A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19).

    Categories: Amino Acids, Peptides, and Proteins